NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Patients scheduled for colonoscopy
Date of first enrollment	21/04/2011
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : AJG522 INN of investigational material : Therapeutic category code : 799 Agents for not mainly purpose of therapeutic, n.e.c. Dosage and Administration for Investigational material : Oral control material(s) Generic name etc : MGV-5 INN of investigational material : Therapeutic category code : 799 Agents for not mainly purpose of therapeutic, n.e.c. Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Colon cleansing effect. Colon cleansing effect will be assessed by the colonoscopy.
Secondary Outcome	Dosage of investigational product administration Cleansing time

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	Patients scheduled for colonoscopy.
Exclude criteria	- Presence or suspicion of gastrointesinal ileus, intestinal perforation or toxic megacolon. - Renal impairment.